Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Atsushi Satake

Showing results (31-40 of 84) with videos related to

Pageof 9
Sort By:
International Journal of Hematology|February 1, 2011
Successful treatment with nilotinib after imatinib failure in a CML patient with a four-way Ph chromosome translocation and point mutations in BCR/ABL geneMasaya Okada, Atsushi Satake, Katsuji Kaida, et al.
Hematology Reports|March 14, 2017
Impact of CRAB Symptoms in Survival of Patients with Symptomatic Myeloma in Novel Agent EraAya Nakaya, Shinya Fujita, Atsushi Satake, et al.
Plos One|November 8, 2024
Elevated plasma progranulin levels in the acute phase are correlated with recovery of left ventricular function in the chronic phase in patients with acute myocardial infarctionShingo Minatoguchi, Atsushi Satake, Hirotaka Murase, et al.
Acta Haematologica|July 21, 2017
Realistic Lenalidomide Dose Adjustment Strategy for Transplant-Ineligible Elderly Patients with Relapsed/Refractory Multiple Myeloma: Japanese Real-World ExperienceAya Nakaya, Shinya Fujita, Atsushi Satake, et al.
Molecular and Clinical Oncology|February 20, 2016
Mogamulizumab treatment of refractory peripheral T-cell lymphoma following autologous stem cell transplantation: A case reportYukie Fujita, Aya Nakaya, Shinya Fujita, et al.
Clinical Case Reports|December 12, 2017
Tyrosine kinase inhibitor and rituximab-CHOP treatment for concurrent chronic myeloid leukemia and non-Hodgkin lymphoma: a case reportYuki Takeyasu, Atsushi Satake, Yoshiko Azuma, et al.
International Journal of Hematology|August 31, 2016
Successful treatment with mogamulizumab followed by allogeneic hematopoietic stem-cell transplantation in adult T-cell leukemia/lymphoma: a report of two casesYukie Tsubokura, Atsushi Satake, Masaaki Hotta, et al.
Leukemia Research|September 26, 2016
Delayed HBV reactivation in rituximab-containing chemotherapy: How long should we continue anti-virus prophylaxis or monitoring HBV-DNA?Aya Nakaya, Shinya Fujita, Atsushi Satake, et al.
[Rinsho Ketsueki] the Japanese Journal of Clinical Hematology|May 13, 2026
[Fibrin-associated large B-cell lymphoma confined to a left atrial myxoma showing durable remission after surgical resection alone]Natsumi Sakai, Masaaki Hotta, Sumire Inoue, et al.
Hematology Reports|October 5, 2018
Clinical significance of dasatinib-induced pleural effusion in patients with de <i>novo</i> chronic myeloid leukemiaAya Nakaya, Shinya Fujita, Atsushi Satake, et al.
Pageof 9

Showing results (31-40 of 84) with videos related to

Sort By:
Pageof 9
International Journal of Hematology|February 1, 2011
Successful treatment with nilotinib after imatinib failure in a CML patient with a four-way Ph chromosome translocation and point mutations in BCR/ABL geneMasaya Okada, Atsushi Satake, Katsuji Kaida, et al.
Hematology Reports|March 14, 2017
Impact of CRAB Symptoms in Survival of Patients with Symptomatic Myeloma in Novel Agent EraAya Nakaya, Shinya Fujita, Atsushi Satake, et al.
Plos One|November 8, 2024
Elevated plasma progranulin levels in the acute phase are correlated with recovery of left ventricular function in the chronic phase in patients with acute myocardial infarctionShingo Minatoguchi, Atsushi Satake, Hirotaka Murase, et al.
Acta Haematologica|July 21, 2017
Realistic Lenalidomide Dose Adjustment Strategy for Transplant-Ineligible Elderly Patients with Relapsed/Refractory Multiple Myeloma: Japanese Real-World ExperienceAya Nakaya, Shinya Fujita, Atsushi Satake, et al.
Molecular and Clinical Oncology|February 20, 2016
Mogamulizumab treatment of refractory peripheral T-cell lymphoma following autologous stem cell transplantation: A case reportYukie Fujita, Aya Nakaya, Shinya Fujita, et al.
Clinical Case Reports|December 12, 2017
Tyrosine kinase inhibitor and rituximab-CHOP treatment for concurrent chronic myeloid leukemia and non-Hodgkin lymphoma: a case reportYuki Takeyasu, Atsushi Satake, Yoshiko Azuma, et al.
International Journal of Hematology|August 31, 2016
Successful treatment with mogamulizumab followed by allogeneic hematopoietic stem-cell transplantation in adult T-cell leukemia/lymphoma: a report of two casesYukie Tsubokura, Atsushi Satake, Masaaki Hotta, et al.
Leukemia Research|September 26, 2016
Delayed HBV reactivation in rituximab-containing chemotherapy: How long should we continue anti-virus prophylaxis or monitoring HBV-DNA?Aya Nakaya, Shinya Fujita, Atsushi Satake, et al.
[Rinsho Ketsueki] the Japanese Journal of Clinical Hematology|May 13, 2026
[Fibrin-associated large B-cell lymphoma confined to a left atrial myxoma showing durable remission after surgical resection alone]Natsumi Sakai, Masaaki Hotta, Sumire Inoue, et al.
Hematology Reports|October 5, 2018
Clinical significance of dasatinib-induced pleural effusion in patients with de <i>novo</i> chronic myeloid leukemiaAya Nakaya, Shinya Fujita, Atsushi Satake, et al.
Pageof 9